An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

NCT00094757 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

521

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Comparator: sitagliptin 100 mg
DRUG: Comparator: sitagliptin 200 mg
DRUG: Comparator: placebo
DRUG: Comparator: pioglitazone

Sponsor

Merck Sharp & Dohme LLC